The medicinal sales forecast for the alimentary tract and metabolism sector in Chile shows a robust upward trend from 2024 to 2028. Starting at 654.8 million USD in 2024, the figures are projected to incrementally rise to 735 million USD by 2028. This optimistic outlook comes after a steady progression in previous years, with the sector standing at 635 million USD in 2023. Year-on-year variations indicate an average increase ranging from 3.1% to 3.3%, cumulatively presenting a compound annual growth rate (CAGR) of approximately 3.1% over the five-year period from 2024 to 2028.
Future trends to watch for include advancements in pharmaceutical technology, regulatory changes, and shifts in healthcare policies that may influence market dynamics. Additionally, rising prevalence of digestive diseases and the growing elderly population in Chile can provide ongoing momentum for sales growth within this segment.
